PENEMS
ESPID Education. Durrmeyer X. 05/06/10; 4843
Dr. Xavier Durrmeyer
Dr. Xavier Durrmeyer

This content is available to ESPID members only


Click here for more information or if you are considering becoming an ESPID member.

Learning Objectives
Discussion Forum (0)
Rate & Comment (0)
After viewing this presentation the participant will be able to:

- Review the current carbapenems therapy criteria for the treatment of multidrug resistant bacteria in pediatrics.
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies